Although there is no consensus in the literature, breast cancer in young women usually is named when it occurs before 40 years old.
KeywordsYoung women Breast cancer Contralateral prophylactic mastectomy Breast conserving surgery Local recurrence
- 2.Boughey J, Attai DJ, Chen SL, et al. Contralateral Prophylactic Mastectomy (CPM) Consensus statement from the American Society of Breast Surgeons: data on CPM outcomes and risks. Ann Surg Oncol. 2016;23(10):3100–5. Publication of a review compiling the results of the main studies on risk-reducing contralateral mastectomy.CrossRefGoogle Scholar
- 3.Hwang ES, Lichtensztajn DY, Gomez SL. Survival after lumpectomy and mastectomy for early stage invasive breast cancer. Cancer. 2013;119:1402–11. Analysis of the California-US database between 1999 and 2014 showing that conservative treatment was associated with better disease-free survival rate, regardless of age and hormonal status. CrossRefGoogle Scholar
- 4.Mahmood U, Morris C, Neuner G, et al. Similar survival with breast conservation therapy or mastectomy in the management of young women with early-stage breast cancer. Int Radiat Oncol Biol Phys. 2012;83(5):1387–93. SSER analysis shows no benefit from mastectomy in young women below 39 years of age and with initial breast cancer CrossRefGoogle Scholar
- 5.Rodosa JC, Eaton A, Stempel M, et al. Evaluation of local and distant recurrence patterns in patients with triple-negative breast cancer according to age. Ann Surg Oncol. 2017;24(3):698–704. A study that evaluated the impact of age on outcome (free survival and disease and metastasis) of patients with triple-negative tumors. Age and type of surgery were not associated with risk of metastasis, but with classic factors such as lymph node staging and lymphovascular invasion. CrossRefGoogle Scholar
© Springer Nature Switzerland AG 2019